Orion Oyj banner
O

Orion Oyj
OMXH:ORNBV

Watchlist Manager
Orion Oyj
OMXH:ORNBV
Watchlist
Price: 67.65 EUR -0.44% Market Closed
Market Cap: €9.5B

Relative Value

The Relative Value of one ORNBV stock under the Base Case scenario is hidden EUR. Compared to the current market price of 67.65 EUR, Orion Oyj is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ORNBV Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

ORNBV Competitors Multiples
Orion Oyj Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FI
Orion Oyj
OMXH:ORNBV
9.5B EUR 5.9 30.6 23.8 23.8
US
Eli Lilly and Co
NYSE:LLY
987.9B USD 15.2 47.9 32.3 34.3
US
Johnson & Johnson
NYSE:JNJ
596.5B USD 6.3 22.3 15.4 19
CH
Roche Holding AG
SIX:ROG
293B CHF 4.8 31.2 13.1 15.3
CH
Novartis AG
SIX:NOVN
249.7B CHF 5.7 23 14.2 18.2
UK
AstraZeneca PLC
LSE:AZN
240.5B GBP 5.5 31.7 17.5 24.7
US
Merck & Co Inc
NYSE:MRK
307.4B USD 4.7 16.8 10.5 12.3
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 344.9 865
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 3.4 10.4 7.7 9
US
Pfizer Inc
NYSE:PFE
156.9B USD 2.5 20.2 7.5 10
US
Bristol-Myers Squibb Co
NYSE:BMY
125.6B USD 2.6 17.8 7.4 9.2
P/E Multiple
Earnings Growth PEG
FI
O
Orion Oyj
OMXH:ORNBV
Average P/E: 25.2
30.6
22%
1.4
US
Eli Lilly and Co
NYSE:LLY
47.9
28%
1.7
US
Johnson & Johnson
NYSE:JNJ
22.3
7%
3.2
CH
Roche Holding AG
SIX:ROG
31.2
29%
1.1
CH
Novartis AG
SIX:NOVN
23
15%
1.5
UK
AstraZeneca PLC
LSE:AZN
31.7
26%
1.2
US
Merck & Co Inc
NYSE:MRK
16.8
14%
1.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.4
7%
1.5
US
Pfizer Inc
NYSE:PFE
20.2
26%
0.8
US
Bristol-Myers Squibb Co
NYSE:BMY
17.8
17%
1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FI
O
Orion Oyj
OMXH:ORNBV
Average EV/EBITDA: 44.9
23.8
11%
2.2
US
Eli Lilly and Co
NYSE:LLY
32.3
18%
1.8
US
Johnson & Johnson
NYSE:JNJ
15.4
2%
7.7
CH
Roche Holding AG
SIX:ROG
13.1
5%
2.6
CH
Novartis AG
SIX:NOVN
14.2
9%
1.6
UK
AstraZeneca PLC
LSE:AZN
17.5
11%
1.6
US
Merck & Co Inc
NYSE:MRK
10.5
7%
1.5
IE
E
Endo International PLC
LSE:0Y5F
344.9
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
7.7
7%
1.1
US
Pfizer Inc
NYSE:PFE
7.5
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.4
-12%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FI
O
Orion Oyj
OMXH:ORNBV
Average EV/EBIT: 94.6
23.8
14%
1.7
US
Eli Lilly and Co
NYSE:LLY
34.3
17%
2
US
Johnson & Johnson
NYSE:JNJ
19
6%
3.2
CH
Roche Holding AG
SIX:ROG
15.3
6%
2.6
CH
Novartis AG
SIX:NOVN
18.2
12%
1.5
UK
AstraZeneca PLC
LSE:AZN
24.7
24%
1
US
Merck & Co Inc
NYSE:MRK
12.3
6%
2
IE
E
Endo International PLC
LSE:0Y5F
865
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9
8%
1.1
US
Pfizer Inc
NYSE:PFE
10
-1%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
9.2
-6%
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett